Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (8): 849-854.doi: 10.19982/j.issn.1000-6621.20220060
• Original Articles • Previous Articles Next Articles
Li Yinhong1,2, Liu Fanglin1, Lu Zhenhui3(), Jiang Xin1()
Received:
2022-03-03
Online:
2022-08-10
Published:
2022-08-03
Contact:
Lu Zhenhui,Jiang Xin
E-mail:tcmdoctorlu@163.com;jiangxingao@163.com
Supported by:
CLC Number:
Li Yinhong, Liu Fanglin, Lu Zhenhui, Jiang Xin. Study on the mechanism of Oridonin against pathological damage of tuberculosis[J]. Chinese Journal of Antituberculosis, 2022, 44(8): 849-854. doi: 10.19982/j.issn.1000-6621.20220060
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220060
组别 | Bip蛋白相对 灰度值( | CHOP蛋白相对 灰度值( | peIF2α蛋白相对 灰度值( | IRE1α蛋白相对 灰度值( | pIRE1α蛋白相对 灰度值( |
---|---|---|---|---|---|
空白组 | 1.02±0.09 | 1.02±0.12 | 0.99±0.06 | 1.07±0.07 | 0.94±0.07 |
模型组(6h) | 2.27±0.07a | 1.93±0.08a | 1.75±0.03a | 14.19±0.45a | 5.68±0.19a |
模型组(12h) | 2.28±0.17a | 3.86±0.32a | 2.45±0.17a | 15.76±1.27a | 7.29±0.41a |
模型组(24h) | 3.68±0.07a | 13.02±0.41a | 2.41±0.15a | 15.39±0.88a | 9.45±0.36a |
冬凌草甲素(6h) | 1.85±0.07b | 1.03±0.01b | 1.75±0.42b | 10.48±0.40b | 5.22±0.27 |
冬凌草甲素(12h) | 0.97±0.03c | 3.49±0.09c | 1.31±0.04c | 6.15±0.15c | 4.10±0.08c |
冬凌草甲素(24h) | 2.11±0.17d | 6.44±0.24d | 0.75±0.03d | 10.47±0.36d | 7.23±0.13d |
F值 | 149.510 | 146.073 | 10.489 | 10.294 | 53.538 |
P值 | 0.000 | 0.000 | 0.002 | 0.002 | 0.000 |
组别 | pp65蛋白相对 灰度值( | pJNK蛋白相对 灰度值( | pp38蛋白相对 灰度值( |
---|---|---|---|
空白组 | 1.00±0.06 | 1.01±0.12 | 0.98±0.08 |
模型组(6h) | 1.07±0.03 | 666.00±31.32a | 1.63±0.09a |
模型组(12h) | 0.39±0.02a | 471.80±29.38a | 1.53±0.11a |
模型组(24h) | 0.89±0.06 | 334.70±25.68a | 593.10±52.74a |
冬凌草甲素(6h) | 0.69±0.01b | 296.70±10.14b | 6.82±0.27b |
冬凌草甲素(12h) | 0.28±0.01c | 46.05±0.86c | 1.17±0.08c |
冬凌草甲素(24h) | 0.81±0.00 | 38.74±1.12d | 244.4±4.72d |
F值 | 288.194 | 287.059 | 285.140 |
P值 | 0.000 | 0.000 | 0.000 |
[1] |
Amodio G, Pagliara V, Moltedo O, et al. Structural and Functional Significance of the Endoplasmic Reticulum Unfolded Protein Response Transducers and Chaperones at the Mitochondria-ER Contacts: A Cancer Perspective. Front Cell Dev Biol, 2021, 9: 641194. doi: 10.3389/fcell.2021.641194.
doi: 10.3389/fcell.2021.641194 URL |
[2] |
Forney LA, Stone KP, Wanders D, et al. Sensing and signaling mechanisms linking dietary methionine restriction to the behavioral and physiological components of the response. Front Neuroendocrinol, 2018, 51: 36-45. doi: 10.1016/j.yfrne.2017.12.002.
doi: 10.1016/j.yfrne.2017.12.002 URL |
[3] |
Hwang J, Suh HW, Jeon YH, et al. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nat Commun, 2014, 5: 2958. doi: 10.1038/ncomms3958.
doi: 10.1038/ncomms3958 URL |
[4] |
Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP 3 inflammasome activation by regulating NLRP3 expression. J Immunol, 2009, 183(2): 787-791. doi: 10.4049/jimmunol.0901363.
doi: 10.4049/jimmunol.0901363 pmid: 19570822 |
[5] |
Kim S, Joe Y, Jeong SO, et al. Endoplasmic reticulum stress is sufficient for the induction of IL-1beta production via activation of the NF-kappaB and inflammasome pathways. Innate Immun, 2014, 20(8): 799-815. doi: 10.1177/1753425913508593.
doi: 10.1177/1753425913508593 URL |
[6] |
Sachan M, Srivastava A, Ranjan R, et al. Opportunities and Challenges for Host-Directed Therapies in Tuberculosis. Curr Pharm Des, 2016, 22(17): 2599-2604. doi: 10.2174/1381612822666160128150636.
doi: 10.2174/1381612822666160128150636 URL |
[7] |
Kolloli A, Subbian S. Host-Directed Therapeutic Strategies for Tuberculosis. Front Med (Lausanne), 2017, 4: 171. doi: 10.3389/fmed.2017.00171.
doi: 10.3389/fmed.2017.00171 |
[8] |
马征, 胡春生, 张莹莹. 冬凌草水提物治疗慢性咽炎的临床疗效及其安全性初步研究. 中南大学学报, 2011, 36(2): 170-173. doi: 10.3969/j.issn.1672-7347.2011.02.014.
doi: 10.3969/j.issn.1672-7347.2011.02.014 |
[9] |
Ding Y, Ding C, Ye N, et al. Discovery and development of natural product oridonin-inspired anticancer agents. Eur J Med Chem, 2016, 122: 102-117. doi: 10.1016/j.ejmech.2016.06.015.
doi: S0223-5234(16)30493-7 pmid: 27344488 |
[10] |
He H, Jiang H, Chen Y, et al. Oridonin is a covalent NLRP 3 inhibitor with strong anti-inflammasome activity. Nat Commun, 2018, 9(1): 2550. doi: 10.1038/s41467-018-04947-6.
doi: 10.1038/s41467-018-04947-6 URL |
[11] |
曾庆钟, 刘颖, 郐一贺, 等. 冬凌草甲素对小鼠溃疡性结肠炎内质网应激的作用研究. 重庆医学, 2018, 47(17): 2261-2265. doi: 10.3969/j.issn.1671-8348.2018.17.003.
doi: 10.3969/j.issn.1671-8348.2018.17.003 |
[12] |
宋发军, 吴士筠, 梁建军. 巴东冬凌草的抗菌活性研究. 中南民族大学学报(自然科学版), 2004, 23(4): 9-11. doi: 10.3969/j.issn.1672-4321.2004.04.003.
doi: 10.3969/j.issn.1672-4321.2004.04.003 |
[13] |
Xu Y, Xue Y, Wang Y, et al. Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int Immunopharmacol, 2009, 9(3): 360-365. doi: 10.1016/j.intimp.2009.01.002.
doi: 10.1016/j.intimp.2009.01.002 URL |
[14] |
Mishra BB, Moura-Alves P, Sonawane A, et al. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol, 2010, 12(8): 1046-1063. doi: 10.1111/j.1462-5822.2010.01450.x.
doi: 10.1111/j.1462-5822.2010.01450.x URL |
[15] |
Wong KW, Jacobs WR Jr. Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis. Cell Microbiol, 2011, 13(9): 1371-1384. doi: 10.1111/j.1462-5822.2011.01625.x.
doi: 10.1111/j.1462-5822.2011.01625.x URL |
[16] |
Dorhoi A, Nouailles G, Jörg S, et al. Activation of the NLRP 3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur J Immunol, 2012, 42(2): 374-384. doi: 10.1002/eji.201141548.
doi: 10.1002/eji.201141548 pmid: 22101787 |
[17] |
Abais JM, Xia M, Li G, et al. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia. J Biol Chem, 2014, 289(39): 27159-27168. doi: 10.1074/jbc.M114.567537.
doi: 10.1074/jbc.M114.567537 URL |
[18] |
Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol, 2010, 11(2): 136-140. doi: 10.1038/ni.1831.
doi: 10.1038/ni.1831 URL |
[19] |
Han Y, Xu X, Tang C, et al. Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol, 2018, 16: 32-46. doi: 10.1016/j.redox.2018.02.013.
doi: 10.1016/j.redox.2018.02.013 URL |
[20] |
Oslowski CM, Hara T, O’Sullivan-Murphy B, et al. Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab, 2012, 16(2): 265-273. doi: 10.1016/j.cmet.2012.07.005.
doi: 10.1016/j.cmet.2012.07.005 URL |
[21] |
Lim YJ, Choi JA, Choi HH, et al. Endoplasmic reticulum stress pathway-mediated apoptosis in macrophages contributes to the survival of Mycobacterium tuberculosis. PLoS One, 2011, 6(12): e28531. doi: 10.1371/journal.pone.0028531.
doi: 10.1371/journal.pone.0028531 URL |
[22] |
Song C, Wang Y, Cui L, et al. Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-kappaB pathway. BMC Complement Altern Med, 2019, 19(1): 198. doi: 10.1186/s12906-019-2616-3.
doi: 10.1186/s12906-019-2616-3 URL |
[1] | Dong Xiaowei, Guo Huixin, Zhang Chenchen, Wang Jiawen, He Junlei, Li Guanhai, Li Jianwei, Wen Wenpei. Application value of two-step detection of Mycobacterium tuberculosis infection screening in schools [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 802-807. |
[2] | XIA Hui, ZHENG Yang, SONG Yuan-yuan. Interpretation of the Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex issued by World Health Organization [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 641-645. |
[3] | LIU Hai-ting, LI Dong-shuo, ZHANG Lei, WANG Ning, WANG Bin, DING Yang-ming, YAO Rong, LU Yu. A preliminary study on the synergy and mechanism of pyrifazimine and bedaquiline [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 646-653. |
[4] | DAI Xiao-wei, WANG Nen-han, CHEN Shuang-shuang, YANG Xin-yu, TIAN Li-li, CHEN Hong, ZHANG Hong-tai, LI Chuan-you. Assessing next-generation sequencing for Mycobacterium tuberculosis diagnosis in clinical sputum samples [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 669-679. |
[5] | JIA Hong-yan, DONG Jing, ZHANG Zong-de, PAN Li-ping. Progress and clinical application of immunological detection technology for Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 720-726. |
[6] | HE Yi-jun, CAO Xue-fang, GAO Lei. Interpretation of the Procedure of tuberculin skin test-interferon-gamma release assay two-step testing [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 438-441. |
[7] | DAI Guang-ming, WANG fen, CAO Ting-ming, CHU Hong-qian, HUANG Hai-rong, SUN Zhao-gang. Study on efficiency of Mycobacterium tuberculosis detection by real-time quantitative PCR with different clinical sample types and the improvement by grinding specimen with glass beads [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 450-454. |
[8] | SUN Qing, LIAO Xin-lei, WANG Chen-qian, JIANG Guang-lu, DONG Ling-ling, WANG Fen, ZHAO Li-ping, HUANG Hai-rong, WANG Gui-rong. Characterization of rifampin resistance determining region mutations in tuberculosis patients with GeneXpert MTB/RIF positive RNA polymerase β subunit gene mutation [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 349-353. |
[9] | TIAN Li, ZHOU Wei, HUANG Xing, WU Xian-wei, ZHANG Hui-yong, LU Zhen-hui, ZHANG Shao-yan. Analysis of gene mutation characteristics of isoniazid-resistant Mycobacterium tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 354-361. |
[10] | MA Yan, LU Wei, GAO Lei, CHU Nai-hui, ZHOU Lin, CHENG Shi-ming. To end tuberculosis epidemic needs strengthen the management of screening and preventive treatment of latent tuberculosis infection in high-risk groups [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 209-214. |
[11] | LI Dong-shuo, WANG Bin, LU Yu, XU Jian. Study of expression and function of Mycobacterium tuberculosis membrane protein MmpL5-MmpS5 [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 227-233. |
[12] | FAN Ru, LI Xiao-fei. Research progress of molecular biology detection technology for tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 294-298. |
[13] | SUN Zhao-gang. Attention should be paid to the research and development of Mycobacterium tuberculosis antigen detection technology [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 120-124. |
[14] | WANG Shao-hua, ZHAO Guo-lian, WANG Pei, TAN Xiao-wen, CUI Xiao-li, KANG Lei, DANG Li-yun. Analysis of inconsistency between genotypic and phenotypic results of Mycobacterium tuberculosis rifampicin susceptibility test [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 169-173. |
[15] | ZHANG Can-you, CHEN Hui, FA Li-feng, ZHANG Hui, CHENG Jun. Evaluation of the effects of tuberculosis infection control training courses in China, 2016-2019 [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 174-180. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||